Urokinase Syner-Medica

Urokinase Syner-Medica is a thrombolytic medication used to dissolve blood clots in veins and arteries. It works by activating plasminogen to break down fibrin in clots. Commonly prescribed for clot-related conditions like pulmonary embolism and deep vein thrombosis. Suitable for intraarterial and intravenous administration.

Urokinase is primarily used to treat blood clots that have formed in the body, including conditions like pulmonary embolism, deep vein thrombosis, and arterial thrombosis. It may also be used in catheter clearance to restore blood flow in blocked lines. The medication works by dissolving fibrin, the structural component of clots, helping to restore normal circulation. Always administered under medical supervision.

Urokinase helps restore blood flow by breaking down existing clots, which can reduce symptoms like pain, swelling, or breathing difficulties in clot-related conditions. Some patients may experience mild effects such as bruising or bleeding at the injection site. These effects are generally temporary and monitored during treatment.

Urokinase should only be used under the guidance of a healthcare professional due to the risk of bleeding. Patients with a history of bleeding disorders, recent surgery, or uncontrolled high blood pressure should inform their doctor before treatment. Regular monitoring of blood clotting parameters is typically required during therapy.

Urokinase may interact with medications that affect blood clotting, such as anticoagulants, antiplatelets, or NSAIDs, increasing the risk of bleeding. Combining it with certain herbal supplements, like ginkgo biloba or garlic, may also heighten bleeding risks. Alcohol and some antibiotics can influence its effectiveness or side effects.